Maximum Recommended Daily Dose of Lithium Carbonate in Adults
The maximum recommended daily dose of lithium carbonate for acute mania in adults is 1800 mg/day (600 mg three times daily), which typically produces therapeutic serum lithium levels of 1.0-1.5 mEq/L. 1
Dosing by Clinical Phase
Acute Mania
- Standard dosing: 600 mg three times daily (1800 mg/day total) 1
- This regimen normally produces effective serum lithium levels between 1.0 and 1.5 mEq/L 1
- Serum levels must be monitored twice weekly during the acute phase until both serum level and clinical condition stabilize 1
Long-Term Maintenance Therapy
- Typical maintenance dosing: 300 mg three to four times daily (900-1200 mg/day total) 1
- Target serum lithium levels for maintenance: 0.6-1.2 mEq/L 1
- Some sources recommend maintaining levels between 0.6-0.8 mmol/L, though others favor 0.8-1.2 mmol/L 2
- Serum monitoring should occur at least every two months during uncomplicated maintenance therapy 1
Age-Related Dosing Adjustments
Elderly patients require significantly reduced doses and exhibit toxicity at levels normally tolerated by younger adults 1. The recommended maintenance doses by age are:
- Patients <40 years: 925-1300 mg/day (25-35 mmol) 2
- Patients 40-60 years: 740-925 mg/day (20-25 mmol) 2
- Patients >60 years: 550-740 mg/day (15-20 mmol) 2
Critical Monitoring Requirements
Baseline Laboratory Assessment
Before initiating lithium therapy, obtain: 3
- Complete blood cell counts
- Thyroid function tests
- Urinalysis
- Blood urea nitrogen and creatinine levels
- Serum calcium levels
- Pregnancy test in females of childbearing age
Ongoing Monitoring
- Serum lithium levels should be drawn 8-12 hours after the previous dose (immediately prior to next dose) when concentrations are relatively stable 1
- Once stable dosing is achieved, monitor lithium levels, renal function, thyroid function, and urinalysis every 3-6 months 3
- Total reliance must not be placed on serum levels alone—accurate evaluation requires both clinical and laboratory analysis 1
Important Safety Considerations
Toxicity Thresholds
- Patients abnormally sensitive to lithium may exhibit toxic signs at serum levels of 1.0-1.5 mEq/L 1
- The narrow therapeutic window necessitates careful individualized dosing based on both serum levels and clinical response 1
Renal Considerations
- Renal insufficiency causes considerable reduction in lithium clearance and is considered a contraindication, especially if sodium restriction is required 2
- Lithium is almost exclusively excreted via the kidney as a free ion 2
Special Populations
- During the last months of pregnancy, lithium clearance increases by 30-50% due to increased glomerular filtration rate, requiring dose adjustments 2
- Lithium passes freely into breast milk 2
Dosing Schedule Options
Modern practice supports once-daily or twice-daily dosing rather than three-times-daily schedules 2:
- Standard-release formulations: typically twice or three times daily
- Sustained-release formulations: once-daily evening dose or twice-daily dosing is well-established 2
- Sustained-release preparations result in 30-50% reductions in peak plasma concentrations without major changes in overall drug exposure 2